Skip to main content

Table 1 General characteristics of the patients

From: Impact of viral coinfection and macrolide-resistant mycoplasma infection in children with refractory Mycoplasma pneumoniae pneumonia

Characteristic

No (%)

Total

107

Age (y)

4.268 ± 3.294

Gender, No. (%)

 Male

55(51.40)

 Female

52(48.60)

Underlying diseases, No. (%)

 None

98(91.59)

 Congenital heart disease

5(4.67)

 Congenital biliary atresia

2(1.87)

 Other diseases

2(1.87)

Symptoms and signs

 Fever, No. (%)

100(93.46)

 Duration of fever (d)

7.690 ± 5.770

 Cough, No. (%)

107(100)

 Wheezing, No. (%)

20(18.69)

 Duration of wheezing (d)

0.00(0.00,5.00)

RMPP, No. (%)

56(52.34)

Hypoxemia, No. (%)

16(14.95)

Mechanical ventilation, No. (%)

7(6.54)

Application of glucocorticoids, No. (%)

60(56.07)

Replacement of antibiotics, No. (%)

19(17.76)

7-day course of azithromycin, No. (%)

42(39.25)

Coinfection, No. (%)

60(56.07)

MP with A2063G mutation, No. (%)

60(56.07)

Prognosis after treatment, No. (%)

 Surviving

105(98.13)

 Nonsurviving

2(1.87)

  1. Data are No. (%) of patients, mean ± standard deviation (SD) or median (interquartile range)